mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
1 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |